Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
aprepitant (Emend) (1 trial)
bevacizumab (avastin) (1 trial)
carboplatin (paraplatin) (1 trial)
paclitaxel (taxol) (1 trial)
sitagliptin (januvia) (1 trial)
vorinostat (zolinza) (1 trial)
Carcinoma (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Ovarian Neoplasms (Phase 2)
Uterine Neoplasms (Phase 4)
Vomiting (Phase 4)
Trials (4 total)
Trial APIs (6 total)